Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABAT - Assessment of Perceived Stress in an Observational Study Evaluating a Biopsy-sparing Surveillance Strategy in Kidney Transplant Recipients With Blood and Urinary Biomarkers Predictive of the Absence of Rejection

NCT07917884 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07917884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
ABAT - Assessment of Perceived Stress in an Observational Study Evaluating a Biopsy-sparing Surveillance Strategy in Kidney Transplant Recipients With Blood and Urinary Biomarkers Predictive of the Absence of Rejection
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
February 1, 2027
Completion date
February 1, 2029
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplant, renal transplantation; complication

Arms

As registered; 1 arm.

  • ABAT Study population Collection of blood and urine samples, perceived stress assessment

    The study population will consist of a prospective cohort of kidney transplant followed at Nantes University Hospital over a 12-month inclusion period.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Perceived stress score related to the 1-year surveillance biopsy 12 months

    score ranging from 0 to 10, with higher scores indicating high stress level.

Lead sponsor's other trials

Nantes University Hospital, most recent start first.